ReviewJournal of clinical medicine2022

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease.

Lukasz P Gondek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.